Opportunity Information: Apply for PAR 17 047

The National Institutes of Health (NIH) funding opportunity titled "Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (R01)" (Funding Opportunity Number PAR-17-047) supports research aimed at pinpointing which specific brain cell types, neural circuits, and larger brain networks are especially susceptible to normal brain aging and to Alzheimers disease (AD). The central scientific idea behind the announcement is that AD does not damage the brain uniformly. Instead, certain neurons, supporting cell populations, circuits, and regions show earlier or more severe degeneration. This FOA is focused on defining and characterizing that selective vulnerability across multiple biological scales, from individual cells up through circuits and whole-brain systems, because understanding why some elements fail while others remain comparatively resilient is considered essential for accurately mapping the disease process and for identifying more effective therapeutic strategies.

This opportunity uses the NIH R01 mechanism, meaning it is intended for hypothesis-driven, multi-year research projects that can produce substantial advances in knowledge about AD-related neurobiology. Projects responsive to this FOA would generally be expected to clarify which neural components are most vulnerable, describe how that vulnerability emerges or progresses over time, and illuminate underlying mechanisms that connect cellular changes to circuit dysfunction and network-level breakdown. The emphasis on "cells to networks" highlights that the NIH is encouraging work that does not stop at describing pathology in isolated brain areas, but instead explains how cellular-level susceptibility translates into disrupted communication across circuits and broader brain networks implicated in cognitive decline and other AD symptoms.

The opportunity is categorized as discretionary funding, with the activity category listed as health, and it is associated with CFDA number 93.866. The sponsor is the National Institutes of Health. The source information provided lists an original closing date of 2018-03-06 and a creation date of 2016-11-03. While an award ceiling is not specified in the provided data, the R01 mechanism typically allows budgets and project scopes that fit the scientific aims and NIH policy constraints, and applicants generally frame their requests based on the level of work needed to achieve the proposed objectives.

Eligibility is broad and includes many common applicant types across government, academia, nonprofit, and industry. Eligible applicants include state governments; county governments; city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments that are federally recognized; public housing authorities and Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits with 501(c)(3) status; nonprofits without 501(c)(3) status (in both cases other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. In addition, the FOA explicitly notes other eligible applicants, underscoring an intent to include a wide range of institutions and communities in AD research. These additional eligible groups include Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); Indian/Native American Tribal Governments other than federally recognized; eligible federal agencies; faith-based or community-based organizations; regional organizations; U.S. territories or possessions; and non-domestic (non-U.S.) entities, meaning foreign organizations may also apply.

In practical terms, the FOA is meant to push the field toward a more precise map of where and why AD-related degeneration starts and spreads, and what differentiates vulnerable versus resilient cell populations and networks during aging and AD. By prioritizing selective vulnerability, the announcement is aligned with the broader goal of moving beyond generalized descriptions of AD pathology and toward mechanistic insights that can guide targeted interventions, whether those interventions aim to protect high-risk cell types, stabilize critical circuits, preserve network connectivity, or interrupt the biological cascades that link aging processes to Alzheimers-specific neurodegeneration.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2016-11-03.
  • Applicants must submit their applications by 2018-03-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 17 047

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Alzheimers Disease Research

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Limited Competition: Clinical Trials in Organ Transplantation in Children (CTOT-C): Mechanistic Ancillary Studies (U01)

Previous opportunity: Revision Requests for Active Alzheimer's Disease Research Centers (P50)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 17 047

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 17 047) also looked into and applied for these:

Funding Opportunity
Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimers Disease Risk (R01) Apply for RFA AG 17 061

Funding Number: RFA AG 17 061
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
USAID Child Blindness Program (CBP) Apply for PGRD 16 0004

Funding Number: PGRD 16 0004
Agency: Agency for International Development
Category: Health
Funding Amount: $250,000
Research Career Enhancement Award to Advance Therapy Development for Alzheimer's (K18) Apply for PAR 17 052

Funding Number: PAR 17 052
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Postbaccalaureate Research Education Program (PREP) (R25) Apply for PAR 17 051

Funding Number: PAR 17 051
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Knowledge Management Center for Illuminating the Druggable Genome (U24) Apply for RFA RM 16 024

Funding Number: RFA RM 16 024
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research Education: Initiative for Maximizing Student Development (IMSD) Program (R25) Apply for PAR 17 053

Funding Number: PAR 17 053
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Resource Dissemination and Outreach Center for Illuminating the Druggable Genome (U24) Apply for RFA RM 16 025

Funding Number: RFA RM 16 025
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antimicrobial-Resistant Gram-Negative Bacteria (R01) Apply for RFA AI 16 081

Funding Number: RFA AI 16 081
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,050,000
Leveraging Existing Cohort Studies to Clarify Risk and Protective Factors for Alzheimers Disease and Related Dementias (R01) Apply for PAR 17 054

Funding Number: PAR 17 054
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Enhancing the Target and Biomarker Discovery Efforts of the AMP-AD and M2OVE-AD Consortia (R01) Apply for RFA AG 17 054

Funding Number: RFA AG 17 054
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Global Infectious Disease Research Training Program (D43) Apply for PAR 17 057

Funding Number: PAR 17 057
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Investigator Initiated Extended Clinical Trial (R01) Apply for PAR 17 056

Funding Number: PAR 17 056
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Planning Grant for Global Infectious Disease Research Training Program (D71) Apply for PAR 17 058

Funding Number: PAR 17 058
Agency: National Institutes of Health
Category: Health
Funding Amount: $46,000
Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings (R01) Apply for RFA AG 17 064

Funding Number: RFA AG 17 064
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings (R21/R33) Apply for RFA AG 17 065

Funding Number: RFA AG 17 065
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alzheimer's Disease Outcomes Research Resource (U2C) Apply for RFA AG 17 052

Funding Number: RFA AG 17 052
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Enhancing Cancer Registries for Early Pediatric and Young Adult Cancer Cases Apply for CDC RFA DP14 140204CONT17

Funding Number: CDC RFA DP14 140204CONT17
Agency: Centers for Disease Control - NCCDPHP
Category: Health
Funding Amount: Case Dependent
Limited Competition: Clinical Trials in Organ Transplantation in Children (CTOT-C): Mechanistic Ancillary Studies (U01) Apply for RFA AI 16 078

Funding Number: RFA AI 16 078
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01) Apply for PAR 17 063

Funding Number: PAR 17 063
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Leveraging Existing Resources for Research on Lewy Body Dementia (R03) Apply for RFA NS 17 016

Funding Number: RFA NS 17 016
Agency: National Institutes of Health
Category: Health
Funding Amount: $50,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 17 047", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: